Congenital Hyperinsulinism in Infants with Turner Syndrome: Possible Association with Monosomy X and KDM6A Haploinsufficiency

scientific article published on 14 June 2018

Congenital Hyperinsulinism in Infants with Turner Syndrome: Possible Association with Monosomy X and KDM6A Haploinsufficiency is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1159/000488347
P932PMC publication ID6067979
P698PubMed publication ID29902804

P50authorDiva D De LeónQ79716162
P2093author name stringArupa Ganguly
Changhong Li
Charles A Stanley
Pan Chen
Tricia Bhatti
N Scott Adzick
Vaneeta Bamba
Susan A Becker
Laura Conlin
Kara E Boodhansingh
Christopher E Gibson
P2860cites workExome sequencing identifies MLL2 mutations as a cause of Kabuki syndromeQ24622470
Identification of JmjC domain-containing UTX and JMJD3 as histone H3 lysine 27 demethylasesQ24676547
A histone H3 lysine 27 demethylase regulates animal posterior developmentQ28248320
Deletion of KDM6A, a histone demethylase interacting with MLL2, in three patients with Kabuki syndromeQ28256091
The histone demethylase UTX enables RB-dependent cell fate controlQ28272073
The H3K27me3 demethylase dUTX is a suppressor of Notch- and Rb-dependent tumors in DrosophilaQ33826493
Mechanism of hyperinsulinism in short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency involves activation of glutamate dehydrogenaseQ34181596
Unmasking Kabuki syndromeQ34310239
Care of girls and women with Turner syndrome: a guideline of the Turner Syndrome Study GroupQ34574609
Chromosome abnormalities found among 34,910 newborn children: results from a 13-year incidence study in Arhus, DenmarkQ34618515
Kabuki make-up (Niikawa-Kuroki) syndrome: a study of 62 patientsQ34685121
Mechanisms of mosaicism, chimerism and uniparental disomy identified by single nucleotide polymorphism array analysisQ35135033
Hyperinsulinemic Hypoglycaemia in a Turner Syndrome with Ring (X).Q35598895
How genetically heterogeneous is Kabuki syndrome?: MLL2 testing in 116 patients, review and analyses of mutation and phenotypic spectrumQ35837668
GLP-1 receptor antagonist exendin-(9-39) elevates fasting blood glucose levels in congenital hyperinsulinism owing to inactivating mutations in the ATP-sensitive K+ channelQ36249759
Congenital hyperinsulinism in children with paternal 11p uniparental isodisomy and Beckwith-Wiedemann syndrome.Q36542924
Perspective on the Genetics and Diagnosis of Congenital Hyperinsulinism DisordersQ36716020
Turner's syndrome in Italy: familial characteristics, neonatal data, standards for birth weight and for height and weight from infancy to adulthoodQ36734958
Haploinsufficiency of KDM6A is associated with severe psychomotor retardation, global growth restriction, seizures and cleft palateQ36770275
X-chromosome gene dosage and the risk of diabetes in Turner syndromeQ37341881
Persistent Hyperinsulinism in Kabuki Syndrome 2: Case Report and Literature ReviewQ37345141
Regulating a master regulator: establishing tissue-specific gene expression in skeletal muscleQ37780648
Low-level hyperinsulinism with hypoglycemic spells in an infant with mosaic Turner syndrome and mild Kabuki-like phenotype: a case report and review of the literatureQ38129372
Novel KDM6A (UTX) mutations and a clinical and molecular review of the X-linked Kabuki syndrome (KS2).Q38188009
Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome MeetingQ39433677
Gonadal dysgenesis and leucine-sensitive hypoglycemiaQ41635926
Congenital Hypoglycemia Disorders: New Aspects of Etiology, Diagnosis, Treatment and Outcomes: Highlights of the Proceedings of the Congenital Hypoglycemia Disorders Symposium, Philadelphia April 2016.Q41809055
Functional and Metabolomic Consequences of KATP Channel Inactivation in Human Islets.Q42508897
Impaired insulin secretion in the Turner metabolic syndromeQ44968825
Persistent hyperinsulinemic hypoglycemia and maturity-onset diabetes of the young due to heterozygous HNF4A mutationsQ46759019
Mosaic Turner syndrome and hyperinsulinaemic hypoglycaemiaQ48298110
Current best practice in the management of Turner syndromeQ49985296
Mutation Update for Kabuki Syndrome Genes KMT2D and KDM6A and Further Delineation of X-Linked Kabuki Syndrome Subtype 2.Q50504852
EZH2 and KDM6A act as an epigenetic switch to regulate mesenchymal stem cell lineage specification.Q50715828
MLL2 mosaic mutations and intragenic deletion-duplications in patients with Kabuki syndrome.Q50789773
Further delineation of Kabuki syndrome in 48 well-defined new individuals.Q51933516
Atypical findings in Kabuki syndrome: report of 8 patients in a series of 20 and review of the literature.Q51938985
Hypoglycemia in Kabuki syndrome.Q54482735
Neonatal case of novel KMT2D mutation in Kabuki syndrome with severe hypoglycemiaQ87248919
P433issue6
P921main subjectTurner syndromeQ202849
haploinsufficiencyQ852654
monosomy XQ56014434
P304page(s)413-422
P577publication date2018-06-14
P1433published inHormone Research in PaediatricsQ45126686
P1476titleCongenital Hyperinsulinism in Infants with Turner Syndrome: Possible Association with Monosomy X and KDM6A Haploinsufficiency
P478volume89

Reverse relations

cites work (P2860)
Q92995644Impact of genotype, body weight and sex on the prenatal muscle transcriptome of Iberian pigs
Q92088085Lysine demethylases KDM6A and UTY: The X and Y of histone demethylation
Q64100352The Genetic and Molecular Mechanisms of Congenital Hyperinsulinism

Search more.